List view / Grid view
A joint government and industry investment of £92 million intended…
A joint government and industry investment of £92 million intended to expand UK medicine manufacturing facilities, form part of a new £360 million funding package from the UK government.
Funding to support the UK's life sciences manufacturing, skills and…
Funding to support the UK's life sciences manufacturing, skills and infrastructure has been announced as part of a £650m growth package.
Report finds 2020 was a record-breaking year for investment in…
Report finds 2020 was a record-breaking year for investment in UK biotech, driven by innovation and the COVID-19 pandemic, with growth anticipated to continue into 2021.
According to the BIA, less than four percent of eligible…
According to the BIA, less than four percent of eligible projects received funding from a government programme for early-stage biotech companies.
The fund has already raised $1 billion to support clinical…
The fund has already raised $1 billion to support clinical research of novel antibiotics and intends to bring up to four new antibiotics to market by 2030.
The UK Bioindustry Association industry-led vaccine manufacturing group has welcomed…
The UK Bioindustry Association industry-led vaccine manufacturing group has welcomed a £14 million investment to support COVID-19 vaccine manufacturing.
The UK BioIndustry Association’s bioProcessUK conference saw two awards given…
The UK BioIndustry Association’s bioProcessUK conference saw two awards given to Sharon Grimster and Dr Sarah Goulding for their work in the bioprocessing sector.
Research has revealed that the biotechnology industry was worth £1.3…
Research has revealed that the biotechnology industry was worth £1.3 billion in 2019, marking its third-highest year for investment.
The Secretary of State for Health and Social Care is…
The Secretary of State for Health and Social Care is supporting the continuity of medical supplies if the UK is to leave the EU without a deal.
The BIA is committed ensuring patient access to treatments for…
The BIA is committed ensuring patient access to treatments for rare and very rare conditions, sometimes referred to as orphan and ultra-orphan medicines...
